Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series.

Danielle DunnettEbenezer OloyedeOluwakemi OduniyiBarbara ArroyoOlubanke DzahiniDavid M TaylorSukhi S ShergillEromona Whiskey
Published in: Journal of psychopharmacology (Oxford, England) (2021)
Although penfluridol is unlicensed in the United Kingdom, limited data suggest that this long-acting oral therapy has the potential to be used safely and effectively for the treatment of psychotic disorders. However, more data are required to establish the place of penfluridol and other potential long-acting oral antipsychotic formulations in the treatment of psychotic disorders.